Brian Taylor Slingsby sold $43.4M of Mineralys Therapeutics (MLYS)

Executed Nov 20 2025, disclosed Nov 21 2025, 1 day later.

Value, as filed

$43.4M

1,000,000 sh × $43.35

Executed

Nov 20 2025

the trade date, as filed

Disclosed

Nov 21 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BS Brian Taylor Slingsby Director profile →

Brian Taylor Slingsby (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $43.4M of MLYS (1,000,000 sh × $43.35, as filed), executed Nov 20 2025.

The name

MLYS Mineralys Therapeutics, Inc. MLYS · Healthcare · 51 filings in 24 months ticker →

Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Brian Taylor Slingsby in MLYS

MLYSSALE Mineralys Therapeutics, Inc. $3.0M
104,320 sh × $28.81
Exec Sep 22
Filed Sep 24 · 9:49 PM ET MLYSPURCHASE Mineralys Therapeutics, Inc. $3.5M
259,259 sh × $13.50
Exec Mar 13 2025
Filed Apr 25 2025 · 5:30 PM ET †